PDF herunterladen
Thromb Haemost 2013; 110(06): 1110-1111
DOI: 10.1160/TH13-09-0780
Invited Editorial Focus
Schattauer GmbH

Recurrent venous thromboembolism: a role for ABO blood group?

Francesco Dentali
1   Department of Clinical and Experimental Medicine University of Insubria, Varese, Italy
,
Massimo Franchini
2   Department of Transfusion Medicine and Hematology, “C. Poma” Hospital, Mantova, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 01. Oktober 2013

Accepted after minor revision: 02. Oktober 2013

Publikationsdatum:
30. November 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Einführung zu diesem Artikel:

Non-OO blood type influences the risk of recurrent venous thromboembolismThromb Haemost 2013; 110(12): 1172-1179
DOI: 10.1160/TH13-06-0488

Editorial on: Gandara et al. Thromb Haemost 2013; 1110: 1172-1179.

 

  • References

  • 1 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (Suppl. 23) I4-8.
    PubMedSuche in Google Scholar
  • 2 Kyrle PA, Eichinger S. Clinical scores to predict recurrence risk of venous thromboembolism. Thromb Haemost 2012; 108: 1061-1064.
    Thieme ConnectPubMedSuche in Google Scholar
  • 3 Thaler J, Ay C, Pabinger I. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials. Thromb Haemost 2012; 108: 1042-1048.
    Thieme ConnectPubMedSuche in Google Scholar
  • 4 Spyropoulos AC, McGinn T, Khorana AA. The use of weighted and scored risk assessment models for venous thromboembolism. Thromb Haemost 2012; 108: 1072-1076.
    Thieme ConnectPubMedSuche in Google Scholar
  • 5 Ageno W, Dentali F, Donadini MP, Squizzato A. Optimal treatment duration of venous thrombosis. J Thromb Haemost 2013; 11 (Suppl. 01) 151-160.
    CrossrefPubMedSuche in Google Scholar
  • 6 Angchaisuksiri P. Venous thromboembolism in Asia - an unrecognised and under-treated problem?. Thromb Haemost 2011; 106: 585-590.
    Thieme ConnectPubMedSuche in Google Scholar
  • 7 Wattanakit K, Lutsey PL, Bell EJ. et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 2012; 108: 508-515.
    Thieme ConnectPubMedSuche in Google Scholar
  • 8 Bergrem A, Dahm AE, Jacobsen AF. et al. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study. Thromb Haemost 2012; 108: 1165-1171.
    Thieme ConnectPubMedSuche in Google Scholar
  • 9 Franchini M, Favaloro EJ, Targher G. et al. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012; 49: 137-149.
    CrossrefPubMedSuche in Google Scholar
  • 10 Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med 2013; 51: 1545-1553.
    CrossrefPubMedSuche in Google Scholar
  • 11 Moeller A, Weippert-Kretschmer M, Prinz H. et al. Influence of ABO blood groups on primary hemostasis. Transfusion 2001; 41: 56-60.
    CrossrefPubMedSuche in Google Scholar
  • 12 Gill JC, Endres-Brooks J, Bauer PJ. et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-1695.
    CrossrefPubMedSuche in Google Scholar
  • 13 Wu O, Bayoumi N, Vickers MA. et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-69.
    CrossrefPubMedSuche in Google Scholar
  • 14 Dentali F, Sironi AP, Ageno W. et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a metaanalysis of the literature. Semin Thromb Hemost 2012; 38: 535-548.
    Thieme ConnectPubMedSuche in Google Scholar
  • 15 Muellner SK, Haut ER, Streiff MB. et al. ABO blood group as a potential risk factor for venous thromboembolism in acutely injured patients. Thromb Haemost 2011; 105: 5-13.
    Thieme ConnectPubMedSuche in Google Scholar
  • 16 Jang MJ, Yhim HY, Lee JO. et al. ABO blood types are associated with risk of idiopathic venous thromboembolism in the Korean population. A report from the Korean Venous Thromboembolism Working Party (KVTEWP). Thromb Haemost 2012; 107: 799-801.
    Thieme ConnectPubMedSuche in Google Scholar
  • 17 Tufano A, Coppola A, Nardo A. et al. Non-O blood group as a risk factor for cerebral vein thrombosis. Thromb Haemost 2013; 110: 197-199.
    Thieme ConnectPubMedSuche in Google Scholar
  • 18 Le Gal G, Kovacs MJ, Carrier M. et al. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost 2010; 104: 498-503.
    Thieme ConnectPubMedSuche in Google Scholar
  • 19 Lecumberri R, Alfonso A, Jiménez D. et al. and the RIETE investigators. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Thromb Haemost. 2013 110. Epub ahead of print.
    PubMedSuche in Google Scholar
  • 20 Rodger MA, Kahn SR, Wells PS. et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008; 179: 417-426.
    CrossrefPubMedSuche in Google Scholar
  • 21 Gandara E, Kovacs MJ, Kahn KR. et al. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb Haemost 2013; 110: 1172-1179.
    Thieme ConnectPubMedSuche in Google Scholar
  • 22 Dentali F, Di Minno MND, Turato S. et al. Role of ABO blood group and of thrombophilic abnormalities on the presence of residual vein obstruction after deep-vein thrombosis of the lower limbs. J Thromb Haemost 2013; 11 (Suppl. 02) 392 (abstract).
    PubMedSuche in Google Scholar
  • 23 Cosmi B, Legnani C, Pengo V. et al. PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics). The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs. Thromb Haemost 2013; 109: 510-516.
    Thieme ConnectPubMedSuche in Google Scholar